ERBB2 transcriptomic expression correlated with HER2 protein expression in FTC and increased protein expression correlated with decreased PFI, raising the possible utility of HER2 as a diagnostic, prognostic, and therapeutic marker for canine FTC. This evidence concerns the gene ERBB2 and thyroid cancer, nonmedullary, 2.